Phase 2 Randomized, Noncomparative, Open-Label Study of Aflibercept and Modified Folfox6 in the First-Line Treatment of Metastatic Colorectal Cancer (Affirm)
Date issued
2012Journal title
ANNALS OF ONCOLOGY
Type of content
Publicación de congreso